Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 29, 2026
Boeing (BA) Q2 Results: Revenue Beats at $24.6 Billion as Deliveries Reach Seven-Year High

Boeing (BA) Q2 Results: Revenue Beats at $24.6 Billion as Deliveries Reach Seven-Year High

Key Takeaways

  • Revenue beat expectations: Boeing reported Q2 revenue of $24.6 billion, exceeding the Bloomberg consensus estimate of $24.26 billion and rising 8% year-over-year.
  • Loss wider than anticipated: Core (non-GAAP) loss per share came in at $0.76, well above the $0.28 consensus loss estimate, driven by ongoing profitability challenges.
  • Free cash flow turned positive: Boeing generated $631 million in free cash flow, a significant swing from negative $200 million a year ago and far better than the negative $331 million analysts had forecast.
  • Deliveries hit a seven-year high: The company delivered 171 commercial aircraft in the quarter — the most since 2018 — led by 129 737s and 25 787 Dreamliners.
  • Record backlog: Total company backlog grew to $715 billion, including over 6,200 commercial airplanes, reflecting strong demand at the recent Farnborough Airshow.
  • Stock reacted positively: Shares rose 4.29% to $220.58 following the release, as investors focused on improving production momentum and strengthening cash generation.

Why These Q2 Results Matter in the Turnaround

Boeing's second-quarter 2026 results represent a critical checkpoint in CEO Kelly Ortberg's multi-year turnaround effort. After years of safety crises, production halts, regulatory scrutiny, and cash burn, the aerospace giant is under intense investor pressure to demonstrate that its recovery is gaining traction. The second quarter matters particularly because it captures the impact of Boeing's steadily rising production rates and its ability to convert order backlog into actual deliveries and cash. With 314 commercial deliveries in the first half — the strongest first-half performance since 2018 — these results offered a real-time test of whether higher output can translate into meaningful financial improvement. I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry.

Breaking Down the Reported Numbers

Boeing posted second-quarter 2026 revenue of $24.6 billion, an 8% increase from the prior-year period and above the Bloomberg consensus estimate of $24.26 billion. The revenue beat was driven primarily by 171 commercial aircraft deliveries during the quarter, reflecting higher output across the 737 MAX and 787 Dreamliner programs.

On the bottom line, Boeing recorded a GAAP loss per share of $0.67 and a core (non-GAAP) loss per share of $0.76. The core loss was materially wider than the $0.28 per-share loss that analysts had expected, indicating that profitability challenges persist even as production ramps up.

The standout metric in the report was free cash flow, which swung to $631 million — a dramatic improvement from negative $200 million in the same quarter last year and comfortably above the consensus estimate of negative $331.4 million. Operating cash flow reached $1.4 billion, nearly double the $687.7 million analysts had projected, supported by higher delivery volume and favorable working capital timing. From what I see, this cash generation improvement stands out as a key signal.

Within the Commercial Airplanes segment, revenue rose 8% to $11.8 billion, and the operating margin loss narrowed to (2.7)% from (5.1)% a year ago, signaling gradual improvement in the unit's cost structure. Boeing's record total backlog of $715 billion, including more than 6,200 commercial aircraft, underscores the deep demand side of the story.

On the certification and production front, Boeing confirmed that certification flight testing is complete on both the 737-7 and 737-10 variants, with regulatory approval still expected in 2026. The 777X program achieved a milestone with FAA approval to begin certification flight testing under TIA 4B (Type Inspection Authorization), and the 737 program began transitioning to a production rate of 47 aircraft per month during the quarter. I’m watching this closely with help from Tickeron’s AI Trend Prediction Engine for broader sector context.

Market Reaction and Investor Sentiment

Boeing shares gained 4.29% to $220.58 following the release, suggesting that investors prioritized the positive free cash flow surprise and delivery momentum over the wider-than-expected loss per share. The rally indicates that the market is increasingly valuing Boeing's production recovery and cash generation trajectory as leading indicators, viewing bottom-line losses as transitional costs associated with the ongoing production ramp-up.

Heading into earnings, options markets had priced in a roughly 6.06% implied move, above Boeing's four-quarter average post-earnings swing of 3.95%, reflecting elevated uncertainty. The stock had lost approximately 4% year-to-date and 11% over the trailing twelve months, weighed down by persistent concerns about supply chain constraints, regulatory hurdles, and the pace of the turnaround. The positive reception to these results suggests that investor sentiment may be shifting as tangible operational improvements accumulate.

Forward Outlook and Key Factors to Monitor

Looking ahead, Boeing's ability to sustain and accelerate its production cadence will remain the central factor shaping its financial trajectory. The 737 program's transition to a rate of 47 aircraft per month — and the activation of low-rate initial production on the new 737 North Line in July — are critical steps toward management's broader production targets. Investors should monitor whether supply chain bottlenecks, particularly in aircraft interiors and engines for the 787, constrain further progress.

Certification milestones represent another major catalyst. With flight testing complete on the 737-7 and 737-10, final FAA approval — expected before year-end — would unlock deliveries of these variants and provide a meaningful revenue tailwind. Similarly, the 777X program's entry into TIA 4B certification flight testing marks tangible progress, though first delivery remains a 2027 event following ETOPS (Extended-range Twin-engine Operational Performance Standards) work.

On the financial side, the free cash flow turnaround is encouraging but still modest in absolute terms relative to Boeing's $715 billion backlog. Investors will watch whether the company can build on the $631 million quarterly figure and deliver consistent positive cash generation through the second half of 2026. Margin improvement in the Commercial Airplanes segment will be another area of focus, as the unit's (2.7)% operating margin, while improved, remains in negative territory. Cost discipline amid the production ramp, labor availability, and supplier stability will all influence how quickly Boeing can return to sustained profitability. One thing that stands out here is the need for steady execution on these fronts.

Researching Aerospace Opportunities with Tickeron

In my analysis of names like BA, I often turn to Tickeron’s AI Screener for quick filtering across technical patterns, fundamentals, and AI ratings. It helps surface comparable ideas in the sector efficiently when evaluating production momentum and cash trends like those seen here.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BA

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


BA's RSI Oscillator ascends from oversold territory

The RSI Oscillator for BA moved out of oversold territory on July 22, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In of the 36 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on BA as a result. In of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BA just turned positive on July 28, 2026. Looking at past instances where BA's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

BA moved above its 50-day moving average on August 03, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BA crossed bullishly above the 50-day moving average on August 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BA advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 257 cases where BA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BA broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (29.851) is normal, around the industry mean (10.177). P/E Ratio (82.853) is within average values for comparable stocks, (65.509). BA's Projected Growth (PEG Ratio) (89.292) is very high in comparison to the industry average of (8.169). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (1.910) is also within normal values, averaging (20.017).

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 43.9B. The market cap for tickers in the group ranges from 4.49 to 1.86T. SPCX holds the highest valuation in this group at 1.86T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 4%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 6%. DFSC experienced the highest price growth at 88%, while EVTL experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 9%. For the same stocks of the Industry, the average monthly volume growth was 60% and the average quarterly volume growth was 85%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 66
Price Growth Rating: 52
SMR Rating: 78
Profit Risk Rating: 71
Seasonality Score: -28 (-100 ... +100)
View a ticker or compare two or three
BA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of jetliners, aircraft and related products

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
929 Long Bridge Drive
Phone
+1 703 465-3500
Employees
171000
Web
https://www.boeing.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.